The momentum behind psychedelic policy reform has surged over the past five years—especially within state legislatures. With over 220 bills introduced across 38 states and D.C. since 2020, the field is evolving rapidly. But sustained progress requires a clearer understanding of what’s working—and what’s not.
Sam Chapman
In 2025 it will be 20 years since the Centre for Psychedelic Research began its study of psychedelic drugs in humans, first at Bristol University and then since 2008 at Imperial College London. What started out as an imaging study of the brain mechanisms of psilocybin in collaboration with Robin Carhart-Harris and Amanda Feilding has turned into a life changing body of research that has encompassed many hundreds of colleagues: doctors psychologists and neuroscientists.
David Nutt
State programs' equity, adverse event management, community tensions, integration with mental health system, microdosing, and indigenous community respect are key topics discussed in the video.
Rebecca Martinez, Jonathan Treem, Tracey Tee
Visionaries in Colorado and Oregon are shaping new psychedelic eco-systems by teaching, educating, and building businesses and nonprofits. Dreams are becoming reality in these emerging landscapes.
Jamie Beachy, Steve Elfrink, Martha Hammel, Nate Howard, Meaghan Len Richmond, Barine Majewska
Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26
Kevin Matthews, Joshua Kappel
Psychedelic retreat centers are operating worldwide, with Oregon and Colorado preparing to regulate similar centers. These venues offer access to psychedelic experiences outside clinical settings, raising questions about their differences
Alexandra Pallas, Melissa Stangl, Ann “Annie Oak” Harrison
Indigenous communities are key to the emerging psychedelic industry but often see little benefit. How can companies ensure their inclusion and fair share in the growing market? Join the conversation.
Jeeshan Chowdhury, David Heldreth, Julia Mande
Panel: New psychedelic entrepreneurs discuss unique business structures and financial strategies aligning with values and purpose, rejecting traditional models for innovative, purpose-driven for-profit ventures.
Daniel Tarockoff, Scarlet Masius
Professor Rachelle Sampson and collaborators explore how personal transformative experiences, particularly psychedelic ones, can shape a new form of leadership called emergent leadership that fosters collective intelligence for societal problem-solving.
Bennet A Zelner
Paul Stamets and Pamela Kryskow discuss the diverse history and potential of psilocybin mushrooms, highlighting their cultural and medical significance in human evolution and mental health treatment. Kryskow emphasizes the
Pam Kryskow, Paul Stamets